HUBS vs SGMO · P/E 96, rev $1.79B vs rev $57.8M
HubSpot Inc (HUBS) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the HUBS and SGMO stock pages for the full models.
Not investment advice.